Literature DB >> 17394228

Measuring fatigue in rheumatoid arthritis: a systematic review of scales in use.

S Hewlett1, M Hehir, J R Kirwan.   

Abstract

OBJECTIVE: Fatigue is an important outcome for patients with rheumatoid arthritis (RA). The purpose of this study was to identify the scales being used to measure RA fatigue, and to systematically examine the evidence for their validation.
METHODS: Articles measuring fatigue in RA were sought using the terms RA and fatigue, and RA and tiredness, plus scale, questionnaire, inventory, and checklist. Index articles reporting identifiable RA fatigue data were examined for the fatigue scale used. Index and validation articles for each scale were reviewed for evidence supporting scale validation to measure RA fatigue using a standardized checklist of content, face, criterion, and construct validity, reliability, and sensitivity to change.
RESULTS: A total of 61 index articles used 23 different fatigue scales to measure RA fatigue on 71 occasions. Seventeen scales had either no data on validation in RA or limited evidence. Reasonable evidence of validation was identified for 6 scales, each also having some evidence of sensitivity to change: ordinal scales, the Short Form 36 vitality subscale, the Functional Assessment of Chronic Illness Therapy Fatigue Scale, visual analog scales (VAS), the Profile of Mood States, and the RA-specific Multidimensional Assessment of Fatigue scale (MAF). However, the 4 generic scales would benefit from further validation in patients with RA, the VAS requires standardization, and the MAF would benefit from further sensitivity data.
CONCLUSION: It was possible to identify evidence of reasonable validation for 6 of 23 scales being used to measure RA fatigue. Researchers and clinicians should select scales to measure RA fatigue carefully.

Entities:  

Mesh:

Year:  2007        PMID: 17394228     DOI: 10.1002/art.22611

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  65 in total

1.  Cigarette smoking and self-assessed upper airway health.

Authors:  Thomas Kjærgaard; Milada Cvancarova; Sverre K Steinsvåg
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-05-29       Impact factor: 2.503

2.  Association Between Measures of Fatigue and Health-Related Quality of Life in Rheumatoid Arthritis and Osteoarthritis.

Authors:  Marita Cross; Helen Lapsley; Annica Barcenilla; Peter Brooks; Lyn March
Journal:  Patient       Date:  2008-04-01       Impact factor: 3.883

3.  The role of positive and negative interpersonal events on daily fatigue in women with fibromyalgia, rheumatoid arthritis, and osteoarthritis.

Authors:  Brendt P Parrish; Alex J Zautra; Mary C Davis
Journal:  Health Psychol       Date:  2008-11       Impact factor: 4.267

Review 4.  Biologic interventions for fatigue in rheumatoid arthritis.

Authors:  Celia Almeida; Ernest H S Choy; Sarah Hewlett; John R Kirwan; Fiona Cramp; Trudie Chalder; Jon Pollock; Robin Christensen
Journal:  Cochrane Database Syst Rev       Date:  2016-06-06

5.  Measuring fatigue in rheumatoid arthritis.

Authors:  Stephanie Nikolaus; Mart A F J van de Laar
Journal:  Nat Rev Rheumatol       Date:  2011-08-30       Impact factor: 20.543

Review 6.  [Self-monitoring in inflammatory rheumatic diseases].

Authors:  C Kampling; G Chehab; M Schneider; J G Richter
Journal:  Z Rheumatol       Date:  2014-10       Impact factor: 1.372

7.  Patient-reported Outcomes as Predictors of Change in Disease Activity and Disability in Early Rheumatoid Arthritis: Results from the Yorkshire Early Arthritis Register.

Authors:  Sarah Twigg; Elizabeth M A Hensor; Paul Emery; Alan Tennant; Ann W Morgan
Journal:  J Rheumatol       Date:  2017-07-01       Impact factor: 4.666

8.  Role and rationale for the use of milnacipran in the management of fibromyalgia.

Authors:  Jay D Kranzler; R Michael Gendreau
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-25       Impact factor: 2.570

9.  The visual analogue WOMAC 3.0 scale--internal validity and responsiveness of the VAS version.

Authors:  Paula Kersten; Peter J White; Alan Tennant
Journal:  BMC Musculoskelet Disord       Date:  2010-04-30       Impact factor: 2.362

10.  Physical function improvements and relief from fatigue and pain are associated with increased productivity at work and at home in rheumatoid arthritis patients treated with certolizumab pegol.

Authors:  Johanna M Hazes; Peter Taylor; Vibeke Strand; Oana Purcaru; Geoffroy Coteur; Philip Mease
Journal:  Rheumatology (Oxford)       Date:  2010-06-14       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.